Mike Mensinger, Chief Product Officer at Beta Bionics, Inc. (BBNX), sold 1,064 shares at $12.36 ($13K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Open-market sale of $13k BBNX by Chief Product Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BBNX | SELL | 2026-06-03 | $55K | — | Filing → |
| BBNX | SELL | 2026-01-07 | $66K | — | Filing → |
| BBNX | SELL | 2026-01-05 | $231K | — | Filing → |